Table 1.
Gene | Protein | Frequency in PD | Environmental interactions | Pathogenic variants* | Presumed founder (years) |
Autosomal dominant | |||||
SNCA | Alfa-synuclein | < <1% | Paraquat | A30P | ? |
Rotenone | E46K | ? | |||
H50Q | ? | ||||
G51D | ? | ||||
A53T | ? | ||||
LRRK2 | Leucine-rich repeat kinase 2 | ∼3% | Rotenone | G2019S | ? |
Trichloroethylene | I2020T | ||||
Paraquat | R1441C | ? | |||
R1441G | ? | ||||
R1441H | ? | ||||
N1437H | ? | ||||
Y1699C | ? | ||||
VPS35 | Vacuolar protein sorting-associated protein 35 | <1% | Rotenone | D620N | ? |
Autosomal recessive | |||||
Parkin | Parkin | ∼1% | Paraquat, | R42P | 7,715 |
Rotenone | V65E | ? | |||
K211N | ? | ||||
C212Y | ? | ||||
T415N | ? | ||||
C431F | ? | ||||
C441R | ? | ||||
T240R | ? | ||||
R275W | 4,358 | ||||
G430D | ? | ||||
PINK1 | PTEN induced putative kinase 1 | <1% | Rotenone, | G309D | ? |
MPTP | Q456X | ? | |||
L347P | ? | ||||
G411S | ? | ||||
W437X | ? | ||||
M261I | ? | ||||
DJ-1 | Protein deglycase DJ-1 | < <1% | Rotenone | L166P | ? |
A104T | ? | ||||
Risk factor | |||||
GBA1 | Glucocerebrosidase | 5-15% | MPTP | E326K | 12,525 |
Rotenone | N370S | 7,003 | |||
L444P | 15,010 | ||||
D140H | ? | ||||
T369M | ? | ||||
LRRK2 | Leucine-rich repeat kinase 2 | 5–10% | ? | G2385R | 17,943 |
GWAS risk variant | Intergenic variant (i.e., non-protein-coding) | ∼50% | ? | rs6658353 | 1,036,045 |
Example unrelated to PD | |||||
LRRK2 | Leucine-rich repeat kinase 2 (benign) | M2397T | 888,858 |
This table provides an overview of genetic factors associated with PD, including their environmental interactions and estimated age based on human genome dating database [18]. *A selection of the most common pathogenic variants. For most genes several to tens of other variants exist, but for GBA1 over 400 pathogenic variants have been reported thus far [17].